{
  "url": "https://finance.yahoo.com/news/virology-bacteriology-business-analysis-report-080500558.html",
  "authorsByline": "Research and Markets",
  "articleId": "152581057b3844468f1cb8a6a40efdfe",
  "source": {
    "domain": "finance.yahoo.com",
    "location": {
      "country": "us",
      "state": "CA",
      "county": "Santa Clara County",
      "city": "Sunnyvale",
      "coordinates": {
        "lat": 37.3688301,
        "lon": -122.036349
      }
    }
  },
  "imageUrl": "https://media.zenfs.com/en/globenewswire.com/b407a6f11273ad0ed6c08b01c4ec35b7",
  "country": "us",
  "language": "en",
  "pubDate": "2025-08-12T08:05:00+00:00",
  "addDate": "2025-08-12T08:12:24.133036+00:00",
  "refreshDate": "2025-08-12T08:12:24.133039+00:00",
  "score": 1.0,
  "title": "Virology and Bacteriology Business Analysis Report 2025",
  "description": "The Virology and Bacteriology market is poised for growth driven by technological advances like NGS and CRISPR, crucial for infectious disease research. Key opportunities arise in diagnostics and vaccine development, with robust regional growth, especially in China. Policy initiatives and global health priorities further bolster market expansion. Virology and Bacteriology Market Virology and Bacteriology Market Dublin, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The \"Virology and Bacteriology - Global Str",
  "content": "The Virology and Bacteriology market is poised for growth driven by technological advances like NGS and CRISPR, crucial for infectious disease research. Key opportunities arise in diagnostics and vaccine development, with robust regional growth, especially in China. Policy initiatives and global health priorities further bolster market expansion.\n\nDublin, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The \"Virology and Bacteriology - Global Strategic Business Report\" report has been added to ResearchAndMarkets.com's offering.\n\n\n\nThe global market for Virology and Bacteriology was estimated at US$2.2 Billion in 2024 and is projected to reach US$2.7 Billion by 2030, growing at a CAGR of 3.9% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.\n\n\n\n\n\nVirology and bacteriology, the scientific disciplines focused on the study of viruses and bacteria respectively, form the bedrock of infectious disease research and response. Together, they provide critical insights into the structure, function, genetics, and behavior of the microorganisms responsible for the vast majority of global health threats. Over the past few decades, advances in molecular biology and genomic sequencing have dramatically enhanced the ability to detect, characterize, and understand these pathogens.\n\nWhat Market Forces and Policy Initiatives Are Driving Growth in Virology and Bacteriology Sectors?\n\n\n\nThe growth in the virology and bacteriology market is driven by multiple factors that reflect the growing urgency of infectious disease management, rising investments in healthcare infrastructure, and policy-level commitments to global health security. A major driver is the increasing incidence of infectious disease outbreaks and the heightened awareness of pandemic risks following COVID-19.\n\nGovernments, health organizations, and funding bodies are allocating more resources to research, surveillance, and diagnostic development, creating new opportunities for companies and academic institutions specializing in microbial science. Another important factor is the intensification of antimicrobial resistance, which has spurred initiatives by the World Health Organization, the Centers for Disease Control and Prevention, and the European Union to support new antibiotic pipelines and stewardship programs.\n\nAdditionally, the expansion of biotechnology and pharmaceutical sectors is fostering collaborations that bring together expertise in virology and bacteriology for the development of vaccines, therapeutics, and diagnostics. The rise in global travel and trade is also prompting the establishment of regional disease surveillance hubs and laboratory networks that depend heavily on skilled virology and bacteriology personnel. Regulatory agencies are streamlining approval processes for new technologies in response to urgent public health needs, further accelerating innovation in the sector.",
  "medium": "Article",
  "links": [
    "https://www.researchandmarkets.com/reports/6107118/virology-bacteriology-global-strategic?utm_source=GNE&utm_medium=PressRelease&utm_code=nv7k8p&utm_campaign=2083815+-+Virology+and+Bacteriology+Business+Analysis+Report+2025+%7c+Market+to+Reach+%242.7+Billion+by+2030+-+Biopharmaceutical+Pipeline+Diversification+Spurs+Demand+for+Dual-Discipline+Expertise+and+Platforms&utm_exec=chdomspi"
  ],
  "labels": [
    {
      "name": "Roundup"
    }
  ],
  "claim": "",
  "verdict": "",
  "keywords": [
    {
      "name": "infectious disease research",
      "weight": 0.088099115
    },
    {
      "name": "infectious disease outbreaks",
      "weight": 0.08389131
    },
    {
      "name": "infectious disease management",
      "weight": 0.08347872
    },
    {
      "name": "global health priorities",
      "weight": 0.081860065
    },
    {
      "name": "global health threats",
      "weight": 0.079873204
    },
    {
      "name": "global health security",
      "weight": 0.07981448
    },
    {
      "name": "regional disease surveillance hubs",
      "weight": 0.077844754
    },
    {
      "name": "urgent public health needs",
      "weight": 0.07010852
    },
    {
      "name": "new opportunities",
      "weight": 0.06910152
    },
    {
      "name": "health organizations",
      "weight": 0.067984946
    }
  ],
  "topics": [],
  "categories": [
    {
      "name": "Health"
    }
  ],
  "taxonomies": [
    {
      "name": "/News/Business News/Other",
      "score": 0.8642578125
    },
    {
      "name": "/Business & Industrial/Pharmaceuticals & Biotech",
      "score": 0.81640625
    },
    {
      "name": "/Business & Industrial/Advertising & Marketing/Marketing",
      "score": 0.61474609375
    },
    {
      "name": "/News/Health News",
      "score": 0.46044921875
    },
    {
      "name": "/Health/Health Foundations & Medical Research",
      "score": 0.406005859375
    }
  ],
  "sentiment": {
    "positive": 0.7402559,
    "negative": 0.026442293,
    "neutral": 0.23330179
  },
  "summary": "The global market for Virology and Bacteriology is set to grow, driven by technological advances like NGS and CRISPR, crucial for infectious disease research. The market is expected to reach US$2.7 billion by 2030, growing at a CAGR of 3.9% from 2024 to 2030. Key opportunities arise in diagnostics and vaccine development, particularly in China. The growth is driven by multiple factors including the increasing incidence of infectious disease outbreaks and increased awareness of pandemic risks following COVID-19. The expansion of biotechnology and pharmaceutical sectors is fostering collaborations that bring together expertise in virology and bacteriology for the development of vaccines, therapeutics, and diagnostics.",
  "shortSummary": "The Virology and Bacteriology market, driven by technological advances and global health commitments, is expected to reach $2.7 billion by 2030.",
  "translation": "",
  "translatedTitle": "",
  "translatedDescription": "",
  "translatedSummary": "",
  "reprint": true,
  "reprintGroupId": "ec95ef693e8b4da68973ccba3cae3e6c",
  "places": [],
  "scraped_sources": [
    {
      "url": "https://www.researchandmarkets.com/reports/6107118/virology-bacteriology-global-strategic?utm_source=GNE&utm_medium=PressRelease&utm_code=nv7k8p&utm_campaign=2083815+-+Virology+and+Bacteriology+Business+Analysis+Report+2025+%7c+Market+to+Reach+%242.7+Billion+by+2030+-+Biopharmaceutical+Pipeline+Diversification+Spurs+Demand+for+Dual-Discipline+Expertise+and+Platforms&utm_exec=chdomspi",
      "text": "The global market for Virology and Bacteriology was estimated at US$2.2 Billion in 2024 and is projected to reach US$2.7 Billion by 2030, growing at a CAGR of 3.9% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Virology and Bacteriology market.\nSegments: Technology (Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology, Information Technology); End-Use (Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use, Blood Banks End-Use)\nGeographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.\nGlobal Virology and Bacteriology Market - Key Trends & Drivers Summarized\nHow Are Virology and Bacteriology Shaping the Foundation of Modern Infectious Disease Science?\nVirology and bacteriology, the scientific disciplines focused on the study of viruses and bacteria respectively, form the bedrock of infectious disease research and response. Together, they provide critical insights into the structure, function, genetics, and behavior of the microorganisms responsible for the vast majority of global health threats. Over the past few decades, advances in molecular biology and genomic sequencing have dramatically enhanced the ability to detect, characterize, and understand these pathogens. This deeper understanding has proven vital not only for the development of vaccines and antimicrobial therapies but also for the formulation of public health strategies aimed at outbreak containment and prevention. The COVID-19 pandemic underscored the importance of virological research, while the ongoing global challenge of antimicrobial resistance (AMR) has refocused attention on bacteriological surveillance and antibiotic development. Both fields contribute substantially to early warning systems, enabling the identification of zoonotic spillovers and emerging infections before they reach pandemic proportions. Additionally, ongoing work in bacteriophage research and viral vector applications is blurring the traditional boundaries between the two disciplines, highlighting their interconnectedness in therapeutic innovation. From lab-based diagnostics to epidemiological modeling and vaccine design, virology and bacteriology remain essential to confronting old and new microbial threats in an increasingly interconnected world. As pathogens evolve, so too must the scientific tools and collaborative networks that study them, making continued investment in these fields a cornerstone of global health security.What Technological Innovations Are Driving Advances in Virology and Bacteriology Research?\nThe fields of virology and bacteriology have been revolutionized by a wave of technological innovations that are enabling faster, more accurate, and more comprehensive research. One of the most transformative developments is next-generation sequencing (NGS), which allows scientists to decode the entire genomes of viruses and bacteria in a matter of hours. This technology facilitates rapid identification of novel pathogens, tracks the evolution of resistance genes, and supports real-time surveillance of infectious disease outbreaks. In parallel, CRISPR-based gene editing tools are being used to dissect microbial genomes and understand host-pathogen interactions at an unprecedented level of detail. Proteomics, transcriptomics, and metabolomics are further expanding the toolkit for understanding how pathogens function and interact with their hosts. On the diagnostic front, portable PCR machines, biosensors, and point-of-care tests are drastically reducing the time required to identify infectious agents in clinical and field settings. Artificial intelligence and machine learning algorithms are also being used to predict outbreak trends, model drug-target interactions, and assist in the design of vaccines and therapeutics. In laboratory environments, high-throughput screening technologies are allowing researchers to test thousands of compounds against bacteria and viruses simultaneously, accelerating the discovery of new antimicrobials and antivirals. These technological advances are not only making research more efficient but are also democratizing it by making tools more accessible to laboratories around the world. As innovation continues, virology and bacteriology are expected to become even more integrated with digital health and systems biology, enabling a more proactive and personalized approach to infectious disease management.Why Are Virology and Bacteriology Central to Addressing Global Health Challenges?\nIn the face of rising global health threats, the roles of virology and bacteriology have become increasingly central to ensuring public health preparedness and response. Infectious diseases remain one of the leading causes of morbidity and mortality worldwide, particularly in low and middle-income countries. Viral diseases such as HIV, hepatitis, influenza, and more recently, COVID-19, continue to place a heavy burden on healthcare systems and economies. On the other hand, bacterial infections such as tuberculosis, pneumonia, and sepsis remain persistent killers, especially as antimicrobial resistance renders many first-line antibiotics ineffective. Understanding the biology, transmission, and evolution of these pathogens is crucial to developing effective interventions. Virology provides the framework for creating antiviral therapies and designing vaccines, while bacteriology supports the development of antibiotics, probiotics, and infection control protocols. Additionally, the synergy between the two fields is vital in tackling co-infections, such as viral-bacterial pneumonia or HIV-associated tuberculosis. Virology and bacteriology also contribute significantly to veterinary and agricultural health, influencing zoonotic transmission and food safety practices. In humanitarian and emergency contexts, these sciences support outbreak detection and control, minimizing the impact of disease in vulnerable populations. With the increasing incidence of emerging infectious diseases and the globalization of trade and travel, the role of virologists and bacteriologists extends far beyond the laboratory. Their work underpins global initiatives for disease eradication, pandemic preparedness, and the development of resilient healthcare systems capable of responding to evolving microbial threats.What Market Forces and Policy Initiatives Are Driving Growth in Virology and Bacteriology Sectors?\nThe growth in the virology and bacteriology market is driven by multiple factors that reflect the growing urgency of infectious disease management, rising investments in healthcare infrastructure, and policy-level commitments to global health security. A major driver is the increasing incidence of infectious disease outbreaks and the heightened awareness of pandemic risks following COVID-19. Governments, health organizations, and funding bodies are allocating more resources to research, surveillance, and diagnostic development, creating new opportunities for companies and academic institutions specializing in microbial science. Another important factor is the intensification of antimicrobial resistance, which has spurred initiatives by the World Health Organization, the Centers for Disease Control and Prevention, and the European Union to support new antibiotic pipelines and stewardship programs. Additionally, the expansion of biotechnology and pharmaceutical sectors is fostering collaborations that bring together expertise in virology and bacteriology for the development of vaccines, therapeutics, and diagnostics. The rise in global travel and trade is also prompting the establishment of regional disease surveillance hubs and laboratory networks that depend heavily on skilled virology and bacteriology personnel. Regulatory agencies are streamlining approval processes for new technologies in response to urgent public health needs, further accelerating innovation in the sector. Educational institutions are also expanding their programs to produce a new generation of microbiologists equipped to tackle modern challenges. These dynamics are being reinforced by public-private partnerships and international collaborations that aim to harmonize data sharing, research priorities, and funding mechanisms. As infectious disease continues to dominate global health agendas, virology and bacteriology will remain indispensable disciplines at the center of both policy and practice.Scope Of Study:\nThe report analyzes the Virology and Bacteriology market in terms of units by the following Segments, and Geographic Regions/Countries:Segments: Technology (Molecular Diagnostics Technology, Immunoassays Technology, Diagnostic Imaging Technology, Information Technology); End-Use (Hospitals End-Use, Diagnostic Centers End-Use, Research Laboratories End-Use, Blood Banks End-Use)\nGeographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.\nKey Insights:\n- Market Growth: Understand the significant growth trajectory of the Molecular Diagnostics Technology segment, which is expected to reach US$1.3 Billion by 2030 with a CAGR of a 3.8%. The Immunoassays Technology segment is also set to grow at 3.1% CAGR over the analysis period.\n- Regional Analysis: Gain insights into the U.S. market, estimated at $588.9 Million in 2024, and China, forecasted to grow at an impressive 7.2% CAGR to reach $550.9 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.\nWhy You Should Buy This Report:\n- Detailed Market Analysis: Access a thorough analysis of the Global Virology and Bacteriology Market, covering all major geographic regions and market segments.\n- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.\n- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Virology and Bacteriology Market.\n- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.\nKey Questions Answered:\n- How is the Global Virology and Bacteriology Market expected to evolve by 2030?\n- What are the main drivers and restraints affecting the market?\n- Which market segments will grow the most over the forecast period?\n- How will market shares for different regions and segments change by 2030?\n- Who are the leading players in the market, and what are their prospects?\nReport Features:\n- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.\n- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.\n- Company Profiles: Coverage of players such as Abbott Laboratories, Agilent Technologies Inc., Becton, Dickinson and Company, bioM\u00e9rieux S.A., Bio-Rad Laboratories, Inc. and more.\n- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.\nSome of the 36 companies featured in this Virology and Bacteriology market report include:\n- Abbott Laboratories\n- Agilent Technologies Inc.\n- Becton, Dickinson and Company\n- bioM\u00e9rieux S.A.\n- Bio-Rad Laboratories, Inc.\n- Bruker Corporation\n- Cepheid (Danaher)\n- Charles River Laboratories\n- F. Hoffmann-La Roche Ltd\n- Hologic, Inc.\n- Illumina, Inc.\n- Lonza Group AG\n- Merck KGaA\n- PerkinElmer, Inc.\n- QIAGEN N.V.\n- QuidelOrtho Corporation\n- Shimadzu Corporation\n- Sysmex Corporation\n- Thermo Fisher Scientific Inc.\n- ZEISS Group\nThis edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:\n- Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.\n- Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.\n- Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.\n- Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.\n- Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.\n- Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.\n- Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.\nTable of Contents\nI. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION\n1. MARKET OVERVIEW\n3. MARKET TRENDS & DRIVERS\n4. GLOBAL MARKET PERSPECTIVE\nUNITED STATES\nJAPAN\nCHINA\nEUROPE\nFRANCE\nGERMANY\nUNITED KINGDOM\nASIA-PACIFIC\nAUSTRALIA\nINDIA\nLATIN AMERICA\nMIDDLE EAST\nAFRICA\nCompanies Mentioned (Partial List)\nA selection of companies mentioned in this report includes, but is not limited to:\n- Abbott Laboratories\n- Agilent Technologies Inc.\n- Becton, Dickinson and Company\n- bioM\u00e9rieux S.A.\n- Bio-Rad Laboratories, Inc.\n- Bruker Corporation\n- Cepheid (Danaher)\n- Charles River Laboratories\n- F. Hoffmann-La Roche Ltd\n- Hologic, Inc.\n- Illumina, Inc.\n- Lonza Group AG\n- Merck KGaA\n- PerkinElmer, Inc.\n- QIAGEN N.V.\n- QuidelOrtho Corporation\n- Shimadzu Corporation\n- Sysmex Corporation\n- Thermo Fisher Scientific Inc.\n- ZEISS Group\nTable Information\n| Report Attribute | Details |\n|---|---|\n| No. of Pages | 279 |\n| Published | August 2025 |\n| Forecast Period | 2024 - 2030 |\n| Estimated Market Value in 2024 | 2.2 Billion |\n| Forecasted Market Value by 2030 | 2.7 Billion |\n| Compound Annual Growth Rate | 3.9% |\n| Regions Covered | Global |"
    }
  ],
  "argos_summary": "The global Virology and Bacteriology market is projected to grow from $2.2 billion in 2024 to $2.7 billion by 2030, with a CAGR of 3.9%. This growth is driven by advancements in technologies such as NGS and CRISPR, increasing investments in healthcare, and heightened awareness of infectious disease management post-COVID-19. Key opportunities lie in diagnostics and vaccine development, particularly in regions like China, supported by policy initiatives and global health priorities.",
  "argos_id": "EACXMD0CW"
}